These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 23294366)
1. The effect of emulsifying wax on the physical properties of CTAB-based solid lipid nanoparticles (SLN). Siddiqui A; Alayoubi A; Nazzal S Pharm Dev Technol; 2014 Feb; 19(1):125-8. PubMed ID: 23294366 [TBL] [Abstract][Full Text] [Related]
2. Modeling the effect of sonication parameters on size and dispersion temperature of solid lipid nanoparticles (SLNs) by response surface methodology (RSM). Siddiqui A; Alayoubi A; El-Malah Y; Nazzal S Pharm Dev Technol; 2014 May; 19(3):342-6. PubMed ID: 23590412 [TBL] [Abstract][Full Text] [Related]
3. Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants. Keck CM; Kovačević A; Müller RH; Savić S; Vuleta G; Milić J Int J Pharm; 2014 Oct; 474(1-2):33-41. PubMed ID: 25108048 [TBL] [Abstract][Full Text] [Related]
4. Emulsifier Composition of Solid Lipid Nanoparticles (SLN) Affects Mechanical and Barrier Properties of SLN-Protein Composite Films. Wiedenmann V; Oehlke K; van der Schaaf U; Koivula HM; Mikkonen KS; Karbstein HP J Food Sci; 2019 Dec; 84(12):3642-3652. PubMed ID: 31774560 [TBL] [Abstract][Full Text] [Related]
6. Does the commonly used pH-stat method with back titration really quantify the enzymatic digestibility of lipid drug delivery systems? A case study on solid lipid nanoparticles (SLN). Heider M; Hause G; Mäder K Eur J Pharm Biopharm; 2016 Dec; 109():194-205. PubMed ID: 27789354 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax. Kheradmandnia S; Vasheghani-Farahani E; Nosrati M; Atyabi F Nanomedicine; 2010 Dec; 6(6):753-9. PubMed ID: 20599527 [TBL] [Abstract][Full Text] [Related]
8. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid. Attama AA; Müller-Goymann CC Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752 [TBL] [Abstract][Full Text] [Related]
9. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Liu CH; Wu CT; Fang JY Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495 [TBL] [Abstract][Full Text] [Related]
10. Lecithin-based cationic nanoparticles as a potential DNA delivery system. Cui Z; Qiu F; Sloat BR Int J Pharm; 2006 Apr; 313(1-2):206-13. PubMed ID: 16500053 [TBL] [Abstract][Full Text] [Related]
11. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272 [TBL] [Abstract][Full Text] [Related]
12. Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles. Martins S; Tho I; Souto E; Ferreira D; Brandl M Eur J Pharm Sci; 2012 Apr; 45(5):613-23. PubMed ID: 22245538 [TBL] [Abstract][Full Text] [Related]
14. Precipitation, stabilization and molecular modeling of ZnS nanoparticles in the presence of cetyltrimethylammonium bromide. Praus P; Dvorský R; Horínková P; Pospíšil M; Kovář P J Colloid Interface Sci; 2012 Jul; 377(1):58-63. PubMed ID: 22520213 [TBL] [Abstract][Full Text] [Related]
15. Preparation of gold nanoparticles by surfactant-promoted reductive reaction without extra reducing agent. Tang J; Huang J; Man SQ Spectrochim Acta A Mol Biomol Spectrosc; 2013 Feb; 103():349-55. PubMed ID: 23261633 [TBL] [Abstract][Full Text] [Related]
16. Interfacial properties of cetyltrimethylammonium-coated SiO(2) nanoparticles in aqueous media as studied by using different indicator dyes. Bryleva EY; Vodolazkaya NA; McHedlov-Petrossyan NO; Samokhina LV; Matveevskaya NA; Tolmachev AV J Colloid Interface Sci; 2007 Dec; 316(2):712-22. PubMed ID: 17692863 [TBL] [Abstract][Full Text] [Related]
17. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990 [TBL] [Abstract][Full Text] [Related]
18. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Schubert MA; Müller-Goymann CC Eur J Pharm Biopharm; 2005 Sep; 61(1-2):77-86. PubMed ID: 16011893 [TBL] [Abstract][Full Text] [Related]
19. Stability of lipid excipients in solid lipid nanoparticles. Radomska-Soukharev A Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589 [TBL] [Abstract][Full Text] [Related]
20. The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN). Sznitowska M; Wolska E; Baranska H; Cal K; Pietkiewicz J Eur J Pharm Biopharm; 2017 Jan; 110():24-30. PubMed ID: 27815177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]